New York State Senator Liz Krueger (D) says the core of the numerous challenges facing the state's beleaguered cannabis program are being caused by large corporations who seek to dominate the industry.
September 21, 10:55 AM
The recent equity raises by Canopy Growth (NASDAQ: CGC) and Columbia Care (OTC: CCHWF) have sparked curiosity about which multi-state operators (MSOs) may follow suit.
September 19, 8:45 AM
Publicly-traded cannabis company Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) confirmed Monday its change in legal name to The Cannabist Company Holdings Inc. and will rebrand to The Cannabist Company.
September 18, 10:43 AM
Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) cannabis company has entered into subscription agreements with institutional investors for the purchase and sale of 22,244,210 units of the company at CA$1.52 ($1.13) per unit,
Florida’s Cannabis Market Shows Robust Growth: Analyst Examines Who’s On The Rise Amid Changing Landscape
September 15, 10:30 AM
The Florida cannabis market is experiencing impressive growth, setting the stage for the potential legalization of recreational use.
September 11, 2:18 PM
The MSOS ETF (ARCA: MSOS) gained 69.4% between 8/25/23, five days before the blockbuster announcement of an HHS rescheduling recommendation to this past Friday, 9/8/23. Similarly, the EV/Next-Twelve-Month consensus EBITDA multiples for the group in the chart have increased by 27.5%.
September 11, 10:27 AM
Cannabis regulators in New Jersey will begin accepting applications later this month for three more marijuana license categories.
Here’s Where To Buy Legal Weed: First Indian-American In World Opens Shop In Chicago, NY Retailers Get Creative & More
September 5, 9:10 AM
New York's Cannabis Retail Footprint Grows Amid Market Blockage
August 31, 4:34 PM
The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the
August 31, 1:45 PM
Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has